| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8515785 | Medical Hypotheses | 2018 | 25 Pages |
Abstract
The knowledge that mild LVH in absence of LV chamber dilation is not as harmful in such conditions as believed at present could make avoidable some drugs prescription in some stages of the disease. Furthermore, it may allow a better evaluation of the risk profile of patients with LVH undergoing some cardiovascular major events like bypass grafting, myocardial infarction or surgical heart valve replacement.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Gian Luca Iannuzzi, Mauro Maniscalco, Andrea Elia, Anna Scognamiglio, Giuseppe Furgi, Franco Rengo,